A study of 2933 Chinese patients with a transient ischemic attack or minor stroke found that the 42% who had loss-of-function variants CYP2C19 *2 or *3 had lower protection from recurrent TIAs or strokes [100]. This evidence concerns the gene CYP2C19 and Stroke.